Yan Zhang, PhD, Jeanne Stuckey, PhD, Markus Ruetz, PhD, Michael Cianfrocco, PhD, and Wei Cheng, PhD, have been promoted.

The newest version of the heparin reversal drug, described in a recent issue of Advanced Healthcare Materials, adjusted the number of protons bound to it, making the molecule less positive so it would preferentially bind to the highly negative heparin, resulting in a much safer drug.

Recent research achievements from the Giessen lab.

Dr. Meredith Skiba will join the faculty of the Departments of Biological Chemistry and Pharmacology at U-M Medical School in 2025.

A new collaborative study, examined the interaction between three naturally occurring gases — nitric oxide (NO), oxygen, and H2S — during generation of new blood vessels, called angiogenesis.

The Giessen lab publishes a research article in Nature Communications.

An article about a program to promote faculty diversity co-authored by Ruma Banerjee and two research articles by Banerjee lab members and their U-M collaborators have come into view this week.

Assistant Professor Yan Zhang of the Department of Biological Chemistry at U-M Medical School is the recipient of an NSF CAREER award.

2 in 3 parents in national poll say their child ages 5-12 use personal audio devices; pediatrician offers 4 tips to reduce noise exposure risks

PhD student Basila Moochickal Assainar is the first author of a research article in Nature Communications.

Three year old Wonder Woman fan thrives after customized minimally invasive selective dorsal rhizotomy to help symptoms of cerebral palsy and spastic diplegia

A new study links two autism-associated genes together for the first time, potentially revealing a mechanism behind brain changes seen in people with autism.

A study from the University of Michigan Medical School developed off-switches useful for improving the safety of the Type I-C/Cas3 gene editor.

PhD student Mason Myers of the Zhang lab at U-M Medical School is a lead author of "Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications."